Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q3
Sell
-19,000
Closed -$19.6K 214
2023
Q2
$19.6K Hold
19,000
﹤0.01% 209
2023
Q1
$25.8K Hold
19,000
﹤0.01% 146
2022
Q4
$29.1K Buy
19,000
+2,000
+12% +$4.47K ﹤0.01% 163
2022
Q3
$50K Hold
17,000
﹤0.01% 158
2022
Q2
$31K Hold
17,000
﹤0.01% 159
2022
Q1
$74K Buy
17,000
+4,500
+36% +$20.2K 0.01% 139
2021
Q4
$68K Sell
12,500
-4,500
-26% -$42K ﹤0.01% 152
2021
Q3
$233K Buy
17,000
+4,000
+31% +$57.3K 0.02% 141
2021
Q2
$213K Hold
13,000
0.02% 141
2021
Q1
$248K Buy
+13,000
New +$189K 0.02% 133

Other funds holding AMRS

Sabal Trust's AMRS Position: Q3 2023 in Review

Sabal Trust sold out of Amyris Inc. (AMRS) in Q3 2023, closing a stake of 19,000 shares — an estimated $19.6K sold.

Sabal Trust first reported a position in AMRS in Q1 2021 and held it in 10 quarters. The position peaked at $248K in Q1 2021. 18 funds tracked by Wall St. Rank hold AMRS as of Q3 2023.

  • Sabal Trust reported no remaining Amyris Inc. position as of Q3 2023 after selling out during the quarter.
  • Sabal Trust sold 19,000 Amyris Inc. shares in Q3 2023, an estimated $19.6K.
  • Sabal Trust first reported a position in Amyris Inc. in Q1 2021 and held it in 10 quarters.
  • Sabal Trust's Amyris Inc. position peaked at $248K in Q1 2021.
  • 18 funds tracked by Wall St. Rank held Amyris Inc. as of Q3 2023.

Based on Sabal Trust's 13F filing for Q3 2023, filed 11 Oct 2023.